Maximize Returns with AI-Powered CRNX Insights

CRNX Forecast

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Insider Sells $664821.34 in Stock - Defense World

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) insider Dana Pizzuti sold 15,089 shares of Crinetics Pharmaceuticals stock in a transaction that occurred on Wednesday, March 20th. The shares were sold at an average price of $44.06, for a total transaction of $664,821.34. Following the transaction, the insider now directly owns 27,786 shares in the company, valued at $1,224,251.16. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

defenseworld.net Mar 24, 2024

Market Forecasts

Bullish / Bearish

Digital Assets / Most Accurate

Trading Strategies

Long Volatility

Short Volatility

Balanced News

Balanced News / Sources

Tech / Memes / Politics

About

About / Pricing / Forum

Contact Helium Trades

2024 © Helium Trades
Privacy Policy & Disclosure

* Disclaimer: Nothing on this website constitutes investment advice, performance data or any recommendation that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person. Helium Trades is not responsible in any way for the accuracy of any model predictions or price data. Any mention of a particular security and related prediction data is not a recommendation to buy or sell that security. Investments in securities involve the risk of loss. Past performance is no guarantee of future results. Helium Trades is not responsible for any of your investment decisions, you should consult a financial expert before engaging in any transaction.